12011802|t|The interaction of serum folate and estradiol levels in Alzheimer's disease.
12011802|a|OBJECTIVES: In vitro and in vivo animal studies suggest that sex steroids, such as estrogens and testosterone, could protect the brain. However, estrogen replacement therapy (ERT) for Alzheimer's disease (AD) in women has not been successful. We hypothesised that the lack of effect of ERT might be related to an interaction between estrogens and some other factor(s) associated with AD. DESIGN, SETTING AND METHODS: We analysed total estrogen (TE) and testosterone (TT) levels in women diagnosed with AD and controls of the Oxford Project To Investigate Memory and Ageing. Because estradiol (TE2) after the menopause is largely derived from estrone (TE1), we computed the ratio TE2/(TE1+TE2) and a total steroid index (TT+TE2+TE1). RESULTS: Women with AD (n=66) had significantly higher levels of TE2 (27+/-13 vs. 21+/-13) and a higher TE2/(TE1+TE2) ratio. Stepwise logistic regression analyses showed that the TE2/(TE1+TE2) ratio was the main sex steroid predictor for AD (O.R.=1.06, 95% C.I.=1.01-1.11, p<0.01). Multiple regression analyses revealed that dementia severity was associated with an interaction between the TE2/(TE1+TE2) ratio and serum folate (B=4.59 (SE=1.48), beta=1.22, 95% C.I.=1.62-7.56, p<0.005). None of the other potential mediators of this association (body mass index, sex hormone binding globulin, homocysteine levels, ApoE genotype, smoking, diabetes, blood pressure) was significant. MAIN FINDINGS: A high ratio of estradiol to total estrogens is associated with AD but, in subjects with a high ratio, the dementia severity was lower in those with high serum folate levels. CONCLUSIONS: If this association is causal, then supplementation with folic acid might be considered in future studies on ERT in AD.
12011802	25	31	folate	Chemical	MESH:D005492
12011802	36	45	estradiol	Chemical	MESH:D004958
12011802	56	75	Alzheimer's disease	Disease	MESH:D000544
12011802	174	186	testosterone	Chemical	MESH:D013739
12011802	261	280	Alzheimer's disease	Disease	MESH:D000544
12011802	282	284	AD	Disease	MESH:D000544
12011802	289	294	women	Species	9606
12011802	461	463	AD	Disease	MESH:D000544
12011802	522	524	TE	Chemical	-
12011802	530	542	testosterone	Chemical	MESH:D013739
12011802	544	546	TT	Chemical	MESH:D013739
12011802	558	563	women	Species	9606
12011802	579	581	AD	Disease	MESH:D000544
12011802	659	668	estradiol	Chemical	MESH:D004958
12011802	670	673	TE2	Gene	8260
12011802	719	726	estrone	Chemical	MESH:D004970
12011802	756	759	TE2	Gene	8260
12011802	765	768	TE2	Gene	8260
12011802	782	789	steroid	Chemical	MESH:D013256
12011802	797	799	TT	Chemical	MESH:D013739
12011802	800	803	TE2	Gene	8260
12011802	819	824	Women	Species	9606
12011802	830	832	AD	Disease	MESH:D000544
12011802	875	878	TE2	Gene	8260
12011802	914	917	TE2	Gene	8260
12011802	923	926	TE2	Gene	8260
12011802	989	992	TE2	Gene	8260
12011802	998	1001	TE2	Gene	8260
12011802	1026	1033	steroid	Chemical	MESH:D013256
12011802	1048	1050	AD	Disease	MESH:D000544
12011802	1135	1143	dementia	Disease	MESH:D003704
12011802	1200	1203	TE2	Gene	8260
12011802	1209	1212	TE2	Gene	8260
12011802	1230	1236	folate	Chemical	MESH:D005492
12011802	1373	1401	sex hormone binding globulin	Gene	6462
12011802	1403	1415	homocysteine	Chemical	MESH:D006710
12011802	1424	1428	ApoE	Gene	348
12011802	1448	1456	diabetes	Disease	MESH:D003920
12011802	1522	1531	estradiol	Chemical	MESH:D004958
12011802	1570	1572	AD	Disease	MESH:D000544
12011802	1613	1621	dementia	Disease	MESH:D003704
12011802	1666	1672	folate	Chemical	MESH:D005492
12011802	1751	1761	folic acid	Chemical	MESH:D005492
12011802	1810	1812	AD	Disease	MESH:D000544
12011802	Negative_Correlation	MESH:D005492	MESH:D003704
12011802	Positive_Correlation	MESH:D000544	8260
12011802	Association	MESH:D004958	MESH:D005492
12011802	Association	MESH:D003704	8260
12011802	Association	MESH:D005492	MESH:D000544
12011802	Association	MESH:D004958	MESH:D000544

